World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
44
Citations
8611
World Ranking
4766
National Ranking
5

Anna Sediva publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Anna Sediva sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 211 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Anna Sediva D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Anna Sediva sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Anna Sediva is affiliated with the University Hospital in Motol in the Czech Republic. Their research spans multiple fields in medicine, with a particular focus on immunology and microbiology. They have contributed extensively to the understanding of immune system disorders and infectious diseases.

The primary areas of study for Sediva include immunology, infectious diseases, genetics, molecular biology, and surgery. Their work covers a variety of key topics such as immunodeficiency and autoimmune disorders, COVID-19 clinical research studies, SARS-CoV-2 and COVID-19 research, immune cell function and interaction, chronic lymphocytic leukemia research, T-cell and B-cell immunology, and blood disorders and treatments.

Anna Sediva has published in several scientific journals, often focusing on clinical and immunological research. Frequent publication venues include:

  • Journal of Clinical Immunology
  • Frontiers in Immunology
  • Journal of Allergy and Clinical Immunology
  • Clinical Immunology
  • Pediatric Allergy and Immunology

Among recent notable papers, the following are included:

  • Human genetic and immunological determinants of critical COVID-19 pneumonia, 2022, Nature
  • Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI), 2020, Allergy
  • Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations, 2021, Journal of Allergy and Clinical Immunology
  • SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?, 2021, The Journal of Experimental Medicine
  • Studying severe long COVID to understand post-infectious disorders beyond COVID-19, 2022, Nature Medicine

Collaboration is a significant aspect of Sediva's work. Frequent co-authors include:

  • Adam Klocperk
  • Markéta Bloomfield
  • Zuzana Paračková
  • Tomáš Milota
  • Filomeen Haerynck

With over 126 publications in medicine and 87 specifically in immunology and microbiology, Sediva's research is situated at the intersection of experimental and clinical investigation. Their contributions address both fundamental immunology and applied clinical research, particularly in immunodeficiency and infectious disease contexts.

Best Publications

  • Clinical picture and treatment of 2212 patients with common variable immunodeficiency

    Benjamin Gathmann;Nizar Mahlaoui;Laurence Gérard;Eric Oksenhendler

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Human genetic and immunological determinants of critical COVID-19 pneumonia

    Unknown

  • Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.

    Tanya I Coulter;Anita Chandra;Chris M Bacon;Judith Babar

  • Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects

    Charlotte Schwab;Annemarie Gabrysch;Peter Olbrich;Virginia Patiño

  • Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib

    V. Koneti Rao;Sharon Webster;Virgil A. S. H. Dalm;Anna Šedivá

  • Primary Sjögren syndrome in the paediatric age: a multicentre survey.

    Rolando Cimaz;Annachiara Casadei;Carlos Rose;Jirina Bartunkova

  • Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry

    Maria Elena Maccari;Hassan Abolhassani;Hassan Abolhassani;Asghar Aghamohammadi;Alessandro Aiuti

  • Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI).

    Milena Sokolowska;Zuzanna M. Lukasik;Zuzanna M. Lukasik;Ioana Agache;Cezmi A. Akdis

  • AIRE deficiency in thymus of 2 patients with Omenn syndrome

    Patrizia Cavadini;William Vermi;Fabio Facchetti;Stefania Fontana

  • Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations.

    Julian Thalhammer;Gerhard Kindle;Alexandra Nieters;Stephan Rusch

  • Gliadin fragments induce phenotypic and functional maturation of human dendritic cells.

    Lenka Palová-Jelínková;Daniela Rozková;Barbara Pecharová;Jirina Bártová

  • AIRE deficiency in thymus of 2 patients with Omenn syndrome

    Unknown

  • SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?

    Vanessa Sancho-Shimizu;Petter Brodin;Aurélie Cobat;Aurélie Cobat;Aurélie Cobat;Catherine M Biggs

  • New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe

    Beáta Soltész;Beáta Tóth;Nadejda Shabashova;Anastasia Bondarenko

  • Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - The 2020 COVID-19 pandemic: A statement from the EAACI-section on pediatrics.

    Helen A. Brough;Omer Kalayci;Anna Sediva;Eva Untersmayr

  • Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils’ but Impaired Monocytes’ and Dendritic Cells’ Responsiveness

    Zuzana Parackova;Irena Zentsova;Marketa Bloomfield;Petra Vrabcova

  • Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid

    Zuzana Liba;Jana Kayserova;Martin Elisak;Petr Marusic

  • Impaired Toll-like receptor 8–mediated IL-6 and TNF-α production in antigen-presenting cells from patients with X-linked agammaglobulinemia

    Klára Sochorová;Rudolf Horváth;Daniela Rožková;Jiří Litzman

  • X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the world

    Zeinab A. El-Sayed;Irina Abramova;Juan Carlos Aldave;Waleed Al-Herz

  • Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndrome

    Sven Kracker;James Curtis;Mohammad A.A. Ibrahim;Anna Sediva

  • Anti-CD20 (rituximab) treatment for atopic eczema.

    Anna Šedivá;Jana Kayserová;Eva Vernerová;Andrea Poloučková

Frequent Co-Authors

Radek Spisek
Radek Spisek Sotio (Czechia)
Bodo Grimbacher
Bodo Grimbacher University of Freiburg
Klaus Warnatz
Klaus Warnatz University of Freiburg
Jean-Laurent Casanova
Jean-Laurent Casanova The University of Texas Southwestern Medical Center
Stephan Ehl
Stephan Ehl University of Freiburg
Milan Macek
Milan Macek Charles University
Conleth Feighery
Conleth Feighery Trinity College Dublin
Despina Moshous
Despina Moshous Necker-Enfants Malades Hospital
Eva Untersmayr
Eva Untersmayr Medical University of Vienna
Filomeen Haerynck
Filomeen Haerynck Ghent University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in combining immunology with healthcare, exploring nursing degree programs can open versatile career pathways. Many students look for the best easiest lpn programs to get into as a starting point. Licensed Practical Nurse (LPN) programs often offer a streamlined admission process, making them accessible for early career entry.

Advancing beyond LPN, students might consider nurse practitioner roles, which require more specialized knowledge. Programs featuring nurse practitioner programs with easy admission can be ideal for those seeking a smoother transition into advanced nursing roles, combining clinical expertise with immunology research applications.

For focused mental health and immunology integration, the best online pmhnp programs offer robust clinical placements that support hands-on experience. These programs prepare psychiatric mental health nurse practitioners with the skills to address immunological factors in mental health conditions.

Additionally, budget-conscious students can explore the cheapest online pmhnp programs to obtain quality education without excessive financial burden. Affordable online pathways help widen access to crucial healthcare roles that intersect with immunology.

Best Scientists Citing Anna Sediva

Trending Scientists